News Related to Center for International Blood and Marrow Transplant Research

Related coverage linked through entity extraction aliases.

CAR T Therapy Shows High Remission Rates in Multiple Myeloma, Communication Improvements Reduce Risks

Feb 26, 2026

CAR T-cell therapy is delivering high remission rates for multiple myeloma patients, with improved handoff communication reducing infection risks. FDA-approved BCMA-targeting products show response rates from 72% to 98% in heavily pretreated patients.

AI Tool Predicts Life-Threatening Transplant Complications Months Before Symptoms Appear

Feb 17, 2026

Researchers developed BIOPREVENT, an AI-based tool that predicts chronic graft-versus-host disease and transplant-related mortality in stem cell and bone marrow transplant patients by analyzing blood biomarkers and clinical data collected 90-100 days post-transplant.